Havens Advisors’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Havens Advisors’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-57,000	Closed	-$1.45M	–	39
2019 Q1	$1.45M	Buy	+57,000	New	+$1.01M	1.4%	21

Havens Advisors's NITE Position: Q2 2019 in Review

Havens Advisors sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 57,000 shares — an estimated $1.45M sold.

Havens Advisors first reported a position in NITE in Q1 2019 and held it in 1 quarter. The position peaked at $1.45M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Havens Advisors reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Havens Advisors sold 57,000 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $1.45M.
Havens Advisors first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Havens Advisors's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.45M in Q1 2019.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Havens Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.